Dan Wilson, CFO, iRhythm : Yes. Maybe with that last part of the question, they can come back at any time. We and maybe just rewind a little bit. So we laid out a twelve month remediation plan to the FDA back in August 2024, so a little more than a year ago. We've been executing against that plan.